Dissociation As a Mechanism of Risk for Interpersonal Victimization Among Adolescent Girls.

Autor: Kouri NA; Wayne State University, Detroit, MI, USA., Simon VA; Wayne State University, Detroit, MI, USA., Partridge T; Wayne State University, Detroit, MI, USA.

Publikováno v: Journal of interpersonal violence [J Interpers Violence] 2025 Jan; Vol. 40 (1-2), pp. 419-442. Date of Electronic Publication: 2024 May 06.

Protocol for isolating immune cells from human gastric muscularis propria for single-cell analysis.

Autor: AlAsfoor S; Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: alasfoor.shefaa@mayo.edu., Bernard CE; Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, MN 55905, USA., Jessen E; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA., Simon VA; Center for Individualized Medicine (CIM), Mayo Clinic, Rochester, MN 55905, USA., Rakhshan F; Center for Individualized Medicine (CIM), Mayo Clinic, Rochester, MN 55905, USA., Cipriani G; Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, MN 55905, USA., Hsi LC; Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, MN 55905, USA., Patraw JA; Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, MN 55905, USA., Carothers KJ; Center for Individualized Medicine (CIM), Mayo Clinic, Rochester, MN 55905, USA., Lau JS; Center for Individualized Medicine (CIM), Mayo Clinic, Rochester, MN 55905, USA., McDonough SJ; Center for Individualized Medicine (CIM), Mayo Clinic, Rochester, MN 55905, USA., Dasari S; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA., Farrugia G; Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, MN 55905, USA., Grover M; Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: grover.madhusudan@mayo.edu.

Publikováno v: STAR protocols [STAR Protoc] 2024 Sep 20; Vol. 5 (3), pp. 103258. Date of Electronic Publication: 2024 Aug 11.

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.

Autor: Pilcher WC; Coultier Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA., Yao L; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA., Gonzalez-Kozlova E; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Pita-Juarez Y; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Karagkouni D; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Acharya CR; MMRF, Norwalk, CT, USA., Michaud ME; Department of Pediatrics, Emory School of Medicine, Atlanta, GA, USA., Hamilton M; MMRF, Norwalk, CT, USA., Nanda S; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Song Y; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA., Sato K; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA., Wang JT; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA., Satpathy S; Department of Biomedical Informatics, Emory School of Medicine, Atlanta, GA, USA., Ma Y; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Schulman J; MMRF, Norwalk, CT, USA., D'Souza D; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jayasinghe RG; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA., Cheloni G; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bakhtiari M; Department of Pediatrics, Emory School of Medicine, Atlanta, GA, USA., Pabustan N; MMRF, Norwalk, CT, USA., Nie K; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Foltz JA; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA., Saldarriaga I; Beth Israel Deaconess Medical Center, Boston, MA, USA., Alaaeldin R; Department of Pediatrics, Emory School of Medicine, Atlanta, GA, USA., Lepisto E; MMRF, Norwalk, CT, USA., Chen R; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Fiala MA; Bone Marrow Transplantation & Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA., Thomas BE; Department of Pediatrics, Emory School of Medicine, Atlanta, GA, USA., Cook A; MMRF, Norwalk, CT, USA., Dos Santos JV; Tisch Cancer Institute, Department of Immunology and Immunotherapy, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chiang IL; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA., Figueiredo I; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Fortier J; Bone Marrow Transplantation & Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA., Slade M; Bone Marrow Transplantation & Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA., Oh ST; Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.; Immunomonitoring Laboratory, Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA., Rettig MP; Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA., Anderson E; Mayo Clinic, Rochester, MN, USA., Li Y; Mayo Clinic, Rochester, MN, USA., Dasari S; Mayo Clinic, Rochester, MN, USA., Strausbauch MA; Mayo Clinic, Rochester, MN, USA., Simon VA; Mayo Clinic, Rochester, MN, USA., Rahman AH; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chen Z; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lagana A; Tisch Cancer Institute, Department of Immunology and Immunotherapy, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., DiPersio JF; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA., Rosenblatt J; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center & Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA., Kim-Schulze S; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Dhodapkar MV; Department of Hematology Oncology, Emory School of Medicine, Atlanta, GA, USA.; Winship Cancer Institute, Emory School of Medicine, Atlanta, GA, USA., Lonial S; Department of Pediatrics, Emory School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta., Kumar S; Mayo Clinic, Rochester, MN, USA., Bhasin SS; Department of Pediatrics, Emory School of Medicine, Atlanta, GA, USA., Kourelis T; Mayo Clinic, Rochester, MN, USA., Vij R; Bone Marrow Transplantation & Leukemia Section, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO, USA., Avigan D; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cancer Center & Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA., Cho HJ; MMRF, Norwalk, CT, USA., Mulligan G; MMRF, Norwalk, CT, USA., Ding L; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO, USA., Gnjatic S; Human Immune Monitoring Center, Tisch Cancer Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Vlachos IS; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Spatial Technologies Unit, Harvard Medical School Initiative for RNA Medicine, Boston, MA, USA.; Cancer Center & Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA., Bhasin M; Department of Pediatrics, Emory School of Medicine, Atlanta, GA, USA.; Department of Biomedical Informatics, Emory School of Medicine, Atlanta, GA, USA.; Coultier Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 May 17. Date of Electronic Publication: 2024 May 17.

Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma.

Autor: Loeuillard E, Li B, Stumpf HE, Yang J, Willhite J, Tomlinson JL, Wang J, Rohakhtar FR, Simon VA, Graham RP, Smoot RL, Dong H, Ilyas SI

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Jul 11. Date of Electronic Publication: 2023 Jul 11.

Global post-translational modification profiling of HIV-1-infected cells reveals mechanisms of host cellular pathway remodeling.

Autor: Johnson JR; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA; Gladstone Institute for Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, USA. Electronic address: jeffrey.johnson@mssm.edu., Crosby DC; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94158, USA., Hultquist JF; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA; Gladstone Institute for Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, USA., Kurland AP; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Adhikary P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Li D; Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA., Marlett J; Viral Vector Core, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Swann J; Viral Vector Core, Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Hüttenhain R; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA; Gladstone Institute for Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, USA., Verschueren E; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA; Gladstone Institute for Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, USA., Johnson TL; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA; Gladstone Institute for Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, USA., Newton BW; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA; Gladstone Institute for Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, USA., Shales M; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA; Gladstone Institute for Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, USA., Simon VA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Beltrao P; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CD10 1SD, UK., Frankel AD; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94158, USA., Marson A; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA; Diabetes Center, University of California San Francisco, San Francisco, CA 94143, USA; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA 94720, USA; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA., Cox JS; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA 94720, USA., Fregoso OI; Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA., Young JAT; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA; Gladstone Institute for Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA 94158, USA. Electronic address: nevan.krogan@ucsf.edu.

Publikováno v: Cell reports [Cell Rep] 2022 Apr 12; Vol. 39 (2), pp. 110690.